BioSpace News Archive

Received Positive CHMP Opinion for ONPATTRO™ in Europe for the Treatment of hATTR Amyloidosis in Adult Patients with Stage 1 or Stage 2 Polyneuropathy and On Track for August 11 PDUFA Date in U.S.

Nalco Water, an Ecolab company, has introduced a molecular-based test for Legionella that provides results 14-times faster than current culture testing methods to help building and cooling tower operators manage public health risks from the waterborne pathogen.

Three of the four largest pharmaceutical companies in the world use Adaptive Compliance Engine™ aka ACE for enterprise quality management functionality.

Applications due September 26, 2018

Abdi Ibrahim, the Turkish pharmaceutical industry leader, has carefully selected rfxcel to implement and support new compliance management and serialisation processing software to ensure full compliance with current and future international legislative requirements ahead of the 2019 EU Falsified Medicines Directive (FMD) deadline.

Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced the appointment of Jon Ellis, Ph.D. as GSK’s designated representative to its board of directors.

The Lubrizol Corporation announces its LifeSciences and Particle Sciences businesses, have received a Notice of Allowance on a device for the delivery of medication to the ear-drum.

Advantia Health is expanding into clinical research.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2018, after the close of market on Thursday, August 9, 2018.

Parata Systems, the leading pharmacy technology provider, renewed its Defense Health Agency (DHA) level Authority to Operate (ATO), allowing Parata to continue supporting customers in the armed forces and furthering the company’s ability to work within the Department of Defense (DoD) and DHA.